Michael Dickinson (@mike_dickinson1) 's Twitter Profile
Michael Dickinson

@mike_dickinson1

Haem/onc @Haem_pmcc_rmh in Melbourne. #Lymphoma Lead #CART Early phase trials. Lymphoma co-Chair @ALLGtrials Views are my own. #lymsm

ID: 27204938

linkhttps://www.petermac.org/users/dr-michael-dickinson calendar_today28-03-2009 09:42:13

1,1K Tweet

2,2K Followers

1,1K Following

Michael Dickinson (@mike_dickinson1) 's Twitter Profile Photo
Michael Dickinson
@mike_dickinson1

a year ago

#Glofitamab now US FDA approved for #DLBCL after 2 prior lines! Highly potent (CR43%),FIXED course, durable responses. This is great for patients let's hope ROW follows! Proud to have contributed to the data underpinning this . #lymsm #ICML17 #ICMLugano bit.ly/3qS8C1F

#Glofitamab now US FDA approved for #DLBCL after 2 prior lines! Highly potent (CR43%),FIXED course, durable responses. This is great for patients let's hope ROW follows! Proud to have contributed to the data underpinning this . #lymsm #ICML17 #ICMLugano bit.ly/3qS8C1F